Rx Medicare

Whilst rates of influenza, particularly the new H1N1 strain (’swine flu’), increase in intensity and geographical spread across Europe, the roll out of the vaccination campaigns is receiving mixed levels of uptake and opposition from anti-vaccine campaigners that puts at risk public health and lives, says the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).

Read More…

Related Posts

• FDA Approves Additional Vaccine For 2009 H1N1 Influenza Virus
• CSL Biotherapies Obtains FDA Licensure For Use Of Its Thimerosal-Free Pandemic Influenza A (H1N1) 2009 Monovalent Vaccine In Children
• Get Smart About Swine Flu H1N1 Swine Flu Vaccine Influenza P
• MANUFACTURING THE H1N1 FLU VACCINE NASAL SPRAY Influenza
• Practice Fusion Identifies 300,000 High-Risk Patients For H1N1 Influenza Vaccine, In-line With CDC Pandemic Guidelines
• Baxter Receives European Commission Approval For CELVAPAN H1N1 Pandemic Influenza Vaccine
• Baxter Receives EMEA Positive Opinion For CELVAPAN H1N1 Pandemic Influenza Vaccine
• Swine Flu: NIAID Set To Launch Clinical Trials To Test 2009 H1N1 Influenza Vaccine Candidates
• Cases Of The 2009 H1N1 Influenza A Virus Confirmed In Crawford And Miami Counties
• First Novel H1N1 Influenza Cases Confirmed In Baldwin, Colbert And Dale Counties
• New H1N1 Cases Continue To Rise Worldwide
• HHS Takes Additional Steps Toward Development Of Vaccine For The Novel Influenza A (H1N1)
• H1N1 Influenza Cases Increase
• First Cases Of Novel H1N1 Influenza Identified In Etowah And Mobile Counties
• 15 Countries Report 615 Swine Flu (influenza A H1N1) Cases Of Infection Among Humans, 2nd May 2009

Tags: cases, efficacy, europe, experts, h1n1, influenza, rise, uptake, urge, vaccine

This entry was posted on Thursday, November 26th, 2009 at 1:11 pm and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.